30 Years of Evidence

Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.

Is the CyberKnife © radiosurgery system effective and safe for patients? An umbrella review of the evidence

Yifan Cheng, Yifei Lin, Youlin Long, Liang Du, Rui Chen, Tengyue Hu, Qiong Guo, Ga Liao, Jin Huang | Future Ocol | 2022

Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional Analysis

Felix Ehret, David Kaul, Lucas Mose, Volker Budach, Peter Vajkoczy, Christoph Fürweger, Alfred Haidenberger, Alexander Muacevic, Felix Mehrhof, Markus Kufeld | Cancers (Basel) | 2022

High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment

Parisi E, Romeo A, Sarnelli A, Ghigi G, Bellia SR, Neri E, Micheletti S, Dipalma B, Arpa D, Furini G, Burgio MA, Genestreti G, Gurioli C, Sanna S, Bovolato P, Rea F, Storme G, Scarpi E, Arienti C, Tesei A, Polico R | Cancer Radiother | 2017

Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife

Huang L, Bai J, Zhang Y, Cui Z, Zhang Z, Li J, Wang J, Yu X, Ling Z, Qu B, Pan L | Front Oncol | 2021

Image-Guided Robotic Radiosurgery for the Management of Spinal Ependymomas

Ehret F, Kufeld M, Fürweger C, Haidenberger A, Windisch P, Senger C, Kord M, Träger M, Kaul D, Schichor C, Tonn JC, Muacevic A | Front Oncol | 2021

The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel

Fatima N, Meola A, Ding VY, Pollom E, Soltys SG, Chuang CF, Shahsavari N, Hancock SL, Gibbs IC, Adler JR, Chang SD.J | Neurosurg | 2021

The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications

Sharpton SR, Oermann EK, Moore DT, Schreiber E, Hoffman R, Morris DE, Ewend MG | Neurosurgery | 2014

Efficacy, safety and outcome of frameless image-guided robotic radiosurgery for brain metastases after whole brain radiotherapy

Lohkamp LN, Vajkoczy P, Budach V, Kufeld M | J Neurooncol | 2018

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases

Martinage G, Geffrelot J, Stefan D, Bogart E, Rault E, Reyns N, Emery E, Makhloufi-Martinage S, Mouttet-Audouard R, Basson L, Mirabel X, Lartigau E, Pasquier D | Front Oncol | 2019

A Second Course of Stereotactic Image-Guided Robotic Radiosurgery for Patients with Cerebral Metastasis

Jiang X, Wang H, Song Y, Wang X, Li F, Dong Y, Wang J, Chen H, Yuan Z | World Neurosurg | 2019

A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases

El Shafie RA, Celik A, Weber D, Schmitt D, Lang K, König L, Bernhardt D, Höne S, Forster T, von Nettelbladt B, Adeberg S, Debus J, Rieken S | J Neurooncol | 2020

Clinical outcome after CyberKnife® radiosurgery re-irradiation for recurrent brain metastases

Berber T, Raturi V, Aksaray F, Hojo H, Fujisawa T, Ohyoshi H | Cancer Radiother | 2021

Ipilimumab and Stereotactic Radiosurgery with CyberKnife® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience

Borzillo V, Di Franco R, Giannarelli D, Cammarota F, Scipilliti E, D’Ippolito E, Petito A, Serra M, Falivene S, Grimaldi AM, Simeone E, Festino L, Vanella V, Trojaniello C, Vitale MG, Madonna G, Ascierto PA, Muto P | Cancers (Basel) | 2021

Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis

Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D’Amico R, Lohr F, Voltolini L, Livi L | Clin Lung Cancer | 2019